CompletedPhase 4

Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study

Thailand100 participantsStarted 2008-02

Plain-language summary

Primary objective The primary objective of this study is to see whether intravenous (IV) NTG 100-200 microgram can effectively help extract retained placenta as compared to placebo, in a randomized controlled multicenter study. Secondary objective is to compare the hypotensive effects of NTG as compared to placebo, including others side effects such as headache, blood loss, or others.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy pregnant patient (ASA classification I ,II ) * Normal pregnancy with at least 28 week gestation Exclusion Criteria: * ASA classification III and up * Having complication of pregnancy such as hypertensive disease of pregnancy,

What they're measuring

successful of placenta extraction

Timeframe: 5 mintues

Trial details

NCT IDNCT00707928

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-12

View on ClinicalTrials.gov More Retained Placenta trials